Patents Assigned to Beijing Institute of Microbiology and Epidemiology
  • Use of fibroblast growth factor 2
    Patent number: 10493129
    Abstract: The present invention provides a novel use of fibroblast growth factor 2 (FGF-2), i.e., a use of FGF-2 in preparation of medicine. The uses of the medicine are the following (a) and/or (b) and/or (c): (a) the prevention and/or treatment of lung injury; (b) the prevention and/or treatment of influenza; (c) the prevention and/or treatment of diseases caused by influenza viruses.
    Type: Grant
    Filed: August 9, 2013
    Date of Patent: December 3, 2019
    Assignee: BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY
    Inventors: Xiliang Wang, Chengyu Jiang, Penghui Yang, Xin Liu, Yueqiang Duan, Li Xing, Chengcai Lai
  • NOVEL ATTENUATED DENGUE VIRUS STRAINS FOR VACCINE APPLICATION
    Publication number: 20150231226
    Abstract: The present invention discloses a method of eliciting an immune response and a method of vaccination comprising administration of a mutated flavivirus. The mutated flavivirus comprises at least one mutation in a nucleic acid sequence encoding for the non-structural protein 5 of the flavivirus sequence resulting in inactivation of the 2?O-methyltransferase.
    Type: Application
    Filed: September 23, 2013
    Publication date: August 20, 2015
    Applicants: Agency for Science, Technology and Research, Novartis AG, Beijing Institute of Microbiology and Epidemiology
    Inventors: Katja Fink, Pei-Yong Shi, Cheng Feng Qin